Bristol-Myers Squibb buy Cantor Fitzgerald
Start price
15.09.23
/
50%
€55.30
Target price
15.09.24
€70.25
Performance (%)
-20.45%
End price
16.09.24
€43.99
Summary
This prediction ended on 16.09.24 with a price of €43.99. The prediction for Bristol-Myers Squibb disappointed with a performance of -20.45%. Cantor_Fitzgerald has a follow-up prediction for Bristol-Myers Squibb where he still thinks Bristol-Myers Squibb is a Buy. A total of €2.19 was paid as dividends for this prediction. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | 9.033% | 9.033% | -10.956% |
| iShares Core DAX® | -1.471% | 1.895% | 25.178% |
| iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
| iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
| iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $75.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€53.40
09.10.23
09.10.23
€71.08
09.10.24
09.10.24
-5.26%
18:49
18:49
